Jennifer A. Wick, Tara Schmidlen, Kendra Grande, Chad Moretz, Kristine Ashcraft, Julia Green, Nicolas Moyer, Burns C. Blaxall

Background
Pharmacogenomics (PGx) is an emerging field. Many drug-gene interactions are known but not yet routinely addressed in clinical practice. Therefore, there is a significant gap in care, necessitating development of implementation strategies.

Objective
The objective of the study was to assess the impact of implementing a PGx practice model which incorporates comprehensive pharmacogenomic risk evaluation, testing and medication optimization administered by 7 PGx-certified ambulatory care pharmacists embedded across 30 primary care clinic sites.

• PMID: 36243653
  
• DOI: 10.1016/j.japh.2022.09.002
• Article on PubMed